GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Athanase Innovation AB (OSTO:ATIN) » Definitions » Asset Impairment Charge

Athanase Innovation AB (OSTO:ATIN) Asset Impairment Charge : kr0.00 Mil (TTM As of Dec. 2020)


View and export this data going back to 2017. Start your Free Trial

What is Athanase Innovation AB Asset Impairment Charge?

Athanase Innovation AB's Asset Impairment Charge for the six months ended in Dec. 2020 was kr0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Dec. 2020 was kr0.00 Mil.


Athanase Innovation AB Asset Impairment Charge Historical Data

The historical data trend for Athanase Innovation AB's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Athanase Innovation AB Asset Impairment Charge Chart

Athanase Innovation AB Annual Data
Trend Jun17 Jun18 Jun19
Asset Impairment Charge
- - -

Athanase Innovation AB Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20
Asset Impairment Charge Get a 7-Day Free Trial - - - - -

Athanase Innovation AB Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Dec. 2020 adds up the semi-annually data reported by the company within the most recent 12 months, which was kr0.00 Mil.


Athanase Innovation AB Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Athanase Innovation AB's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.


Athanase Innovation AB (OSTO:ATIN) Business Description

Traded in Other Exchanges
N/A
Address
Nybrogatan 3, Stockholm, SWE, 114 34
Athanase Innovation AB is an alternative investment firm with exposure to both private and public equity. It invests in innovative companies that benefit from trends such as robotics, digitalization, and automation. The principal revenue stream is initially management fees charged on the external fund capital and investment income of the underlying assets.

Athanase Innovation AB (OSTO:ATIN) Headlines

No Headlines